window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women’s Health

  • Artificial Intelligence,Diagnostics,Digital Health,Medical devices,Women's Health

    Diagnoly launches Fetoly on iOS for real-time fetal ultrasound AI

    Diagnoly has launched its fetal ultrasound AI tool Fetoly on [...]

    April 7, 2026
  • Central Nervous System,Clinical Development,Clinical studies,Global health,Neurosciences,Research & Development,Women's Health

    International Brain Health Conference 2026 to focus on early intervention before dementia

    The inaugural International Brain Health Conference 2026 in Edinburgh will [...]

    February 19, 2026
  • Digital Health,Neurosciences,Partnerships & Funding,Women's Health

    Ultrahuman and Click Therapeutics partner on FDA-authorized digital migraine tool

    Ultrahuman and Click Therapeutics have entered a partnership to develop [...]

    January 15, 2026
  • Drug Development,Obesity,Regulatory Affairs,Women's Health

    Oushk recognised among first to meet new GPhC standards for supplying weight-loss medicines

    The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

    December 29, 2025
  • Chronic diseases,Events and Conferences,Global health,Obesity,Women's Health

    UAE obesity conference highlights global advances shaping the future of obesity care

    The 7th UAE Obesity Conference brought together international experts in [...]

    November 19, 2025
  • Artificial Intelligence,Biotech,Clinical Development,Diagnostics,Digital Health,Drug Development,Global health,Healthcare leadership,Precision medicine,Women's Health

    Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction

    Clairity, an AI-driven precision health company, has raised $43 million [...]

    November 13, 2025
  • Biotech,Clinical Trials,Diagnostics,Women in Pharma,Women's Health

    Beyond the gap: Nordic experts call for investment and collaboration to advance women’s health

    Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]

    October 17, 2025
  • Artificial Intelligence,Clinical studies,Digital Health,Global health,Oncology,Partnerships & Funding,Women's Health

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    October 1, 2025
  • Clinical Trials,Pharmaceuticals and therapeutics,Women's Health

    Affibody reports positive Phase 3 results for izokibep in hidradenitis suppurativa

    Affibody has reported positive 16-week data from a global Phase [...]

    September 23, 2025
  • Middle East,Technology and platforms,Women's Health

    Abu Dhabi Biobank expands access to cord blood banking through NMC Healthcare partnership

    Abu Dhabi Biobank has partnered with NMC Healthcare to expand [...]

    September 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top